Oxford Cancer Vaccine Research Boosted by AI Supercomputer

Researchers at the University of Oxford are using a powerful AI supercomputer to analyze large datasets from cancer patients, aiming to accelerate the development of new cancer vaccines and contribute to the Oxford Neoantigen Atlas, potentially enabling vaccine designs that were previously impossible.